Publicações Científicas 2024 - Outubro

1. Pollock NR, Farias TDJ, Kichula KM, Sauter J, Scholz S, Nii-Trebi NI, et al. The 18th International HLA & Immunogenetics workshop project report: Creating fully representative MHC reference haplotypes. Hla. 2024;103(6):e15568. 10.1111/tan.15568.

2. Arid J, Palma-Dibb RG, Molena KF, Faraoni JJ, Fillus TM, Tanimoto HM, et al. Abrasive challenge effects on enamel and dentin from irradiated human teeth: an in vitro study. Radiat Environ Biophys. 2024. 10.1007/s00411-024-01094-z.

3. Martins OC, Antunes do Livramento VJ, Florêncio de Mesquita C, Correa TL, Fernandes MV, Milioli NJ, et al. The Addition of Endoscopic Sphincterotomy to Biliary Stent Placement and its Impact on the Risk of Adverse Events: An Updated Meta-Analysis of Randomized Controlled Trials. Gastrointest Endosc. 2024. 10.1016/j.gie.2024.05.014.

4. Palavani LB, Mitre LP, Camerotte R, Nogueira BV, Canto GL, Chen HC, et al. Advancements and challenges: immunotherapy therapy in high-grade glioma – a meta-analysis of randomized clinical trials. J Neurooncol. 2024. 10.1007/s11060-024-04813-0.

5. Amaral CA, Pedrão PG, Godoy LR, Guimarães YM, Macedo CAP, Appel M, et al. Agreement between frozen section and histopathology to detect malignancy in adnexal masses according to size and morphology by ultrasound. Rev Bras Ginecol Obstet. 2024;46. 10.61622/rbgo/2024rbgo63.

6. Cho BC, Lu S, Felip E, Spira AI, Girard N, Lee JS, et al. Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC. N Engl J Med. 2024. 10.1056/NEJMoa2403614.

7. Igi WF, Nascimento DMC, Afonso MPC, Mota FL, Nova da Costa LS, Brum EB, et al. Anal intraepithelial neoplasia screening during colonoscopy: a technical proposal. Endoscopy. 2024;56(S 01):E762-e3. 10.1055/a-2387-4051.

8. Pires RC, Gama RR, da Silveira Júnior PS, Teixeira FM, Santos CR, de Castro Capuzzo R. Analysis of durability and replacement of vocal prostheses in total laryngectomy patients at a head and neck surgery referral center. Eur Arch Otorhinolaryngol. 2024;281(1):351-7. 10.1007/s00405-023-08180-w.

9. Barbosa de Sousa A, Rohr P, Silveira HCS. Analysis of mitochondrial DNA copy number variation in Brazilian farmers occupationally exposed to pesticides. Int J Environ Health Res. 2024;34(8):2913-22. 10.1080/09603123.2023.2280147.

10. Monteiro MR, Nunes NCC, Junior A, Fêde ABS, Bretas GO, Souza CP, et al. Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads. Breast Cancer (Dove Med Press). 2024;16:51-70. 10.2147/bctt.S448191.

11. Maida M, Celsa C, Lau LHS, Ligresti D, Baraldo S, Ramai D, et al. The Application of Large Language Models in Gastroenterology: A Review of the Literature. Cancers (Basel). 2024;16(19). 10.3390/cancers16193328.

12. Borges CDJ, Alfonso Rodriguez Elvir F, Silva Santana L, Michaela de Oliveira H, Laura Lima Larcipretti A, Muniz Vieira de Melo T, et al. Asleep versus awake GPi DBS surgery for Parkinson’s disease: A systematic review and meta-analysis. J Clin Neurosci. 2024;123:196-202. 10.1016/j.jocn.2024.03.033.

13. Reis MT, Matsushita M, Santos W, de Lima MA, Guimarães DP, Reis RM. Assessing the applicability and interobserver variability of tumor budding and poorly differentiated clusters in colorectal cancer. Surgical Experimental Pathology. 2024;7(1):1. 10.1186/s42047-024-00144-6.

14. Menezes PFL, Esper Treml R, Caldonazo T, Kirov H, da Silva BC, de Oliveira A, et al. Association between delta anion gap/delta bicarbonate and outcome of surgical patients admitted to intensive care unit. BMC Anesthesiol. 2024;24(1):363. 10.1186/s12871-024-02564-z.

15. Pirola WE, Barroso EM, Gama RR, dos Santos Neto MF, Teodoro VA, da Silva Tozzo FCB, et al. Association between periodontal disease and breast cancer: systematic review and meta-analysis. Revista Eletrônica Acervo Saúde. 2024;24(2):e15386-e. 10.25248/reas.e15386.2024.

16. Fernandes BB, Datorre JG, Vazquez FL, Peters ACC, Coracin FL, Reis RM, et al. Association of Fusobacterium nucleatum Levels by ddPCR in Oral Rinse Samples With Periodontal Disease in Oral Squamous Cell Carcinoma Patients and in Controls. J Oral Pathol Med. 2024. 10.1111/jop.13580.

17. Gogas H, Ravimohan S, Datta A, Chhibber A, Couselo EM, Diab A, et al. Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ Precis Oncol. 2024;8(1):150. 10.1038/s41698-024-00641-7.

18. Fungaro Rissatti L, Wilson D, Palace-Berl F, de Mello Ponteciano B, Sardela de Miranda F, Alece Arantes Moreno I, et al. BDNF methylation associated with stress in women: Novel insights in epigenetics and inflammation. Brain, Behavior, & Immunity – Health. 2024;42:100900. 10.1016/j.bbih.2024.100900.

19. Tannir NM, Formiga MN, Penkov K, Kislov N, Vasiliev A, Gunnar Skare N, et al. Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09). J Clin Oncol. 2024;42(23):2800-11. 10.1200/jco.23.02082.

20. Vince CSC, Brassesco MS, Mançano BM, Gregianin LJ, Carbone EK, do Amaral ECA, et al. Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology. JCO Precis Oncol. 2024;8:e2300713. 10.1200/po.23.00713.

21. Palavani LB, Verly G, Borges P, Neto L, Almeida M, Leite M, et al. Beyond surgical resection: evaluating stereotactic brachytherapy iodine-125 for low-grade gliomas: a systematic review and meta-analysis. Neurosurg Rev. 2024;47(1):617. 10.1007/s10143-024-02839-6.

22. Casali BC, Baptista MP, Pachane BC, Cortez AA, Altei WF, Selistre-de-Araújo HS. Blockage of αvβ3 integrin in 3D culture of triple-negative breast cancer and endothelial cells inhibits migration and discourages endothelial-to-mesenchymal plasticity. Biochem Biophys Rep. 2024;38:101686. 10.1016/j.bbrep.2024.101686.

23. Lobo MM, Wainstein AJA, Barros AV, Oliveira AF, Jafelicci AS, Molina AS, et al. Brazilian Society of Surgical Oncology recommendations on Merkel cell carcinoma surgical treatment. J Surg Oncol. 2024. 10.1002/jso.27728.

24. Bugano DDG, Santos VM, Campos-Bragagnoli A, Melo JCM, Romagnolo LGC, Barbosa Neto O, et al. Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer. Clin Colorectal Cancer. 2024. 10.1016/j.clcc.2024.03.003.

25. Gabela A, Wösten-van Asperen RM, Arias AV, Acuña C, Zebin ZA, Lopez-Baron E, et al. The burden of pediatric critical illness among pediatric oncology patients in low- and middle-income countries: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2024;203:104467. 10.1016/j.critrevonc.2024.104467.

26. Zanon JR, Simioni EB, Barbin FF, Pedrão PG, Andrade C, de Andrade DAP, et al. Can CA-125/CEA ratio be used for the differential diagnosis between ovarian and non-ovarian cancers? A research letter. Int J Surg. 2024. 10.1097/js9.0000000000002015.

27. Buralli R, Ribeiro A, Cremonese C, Vineis P, Meyer A. Cancer mortality and premature deaths among hairdressers in Brazil. Environ Res. 2024;244:117942. 10.1016/j.envres.2023.117942.

28. Pilz MJ, Seyringer S, Singer S, Ioannidis G, Sykiotis GP, Arraras JI, et al. The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer. Thyroid. 2024. 10.1089/thy.2024.0396.

29. Dutra JPP, Macedo AVS, Peixoto T, Garcez JDS, Bacchiega BC, Marchi P, et al. Cardiology and oncology: a meeting of giants. Rev Assoc Med Bras (1992). 2024;70(suppl 1):e2024S114. 10.1590/1806-9282.2024s114.

30. Gouveia AG, Viani GA, Bratti VF, Marta GN, Hanna SA, Jacinto AA, et al. Challenges in building radiotherapy capacity: A longitudinal study evaluating eight years of the Brazilian radiotherapy expansion plan. J Cancer Policy. 2024;39:100459. 10.1016/j.jcpo.2023.100459.

31. Paiva CE, Paiva BSR. Challenging Rationality: Examining the Belief in Cure Among Patients With Advanced Incurable Cancers. Oncologist. 2024;29(2):e296-e7. 10.1093/oncolo/oyad284.

32. Aguiar Freitas AJ, Nunes CR, Mano MS, Causin RL, Calfa S, de Oliveira MA, et al. Circulating microRNAs as potential biomarkers in triple-negative breast cancer: a translational research study of the NACATRINE trial. Future Oncol. 2024;20(1):25-38. 10.2217/fon-2023-0886.

33. Cardoso IIV, Rosa MN, Moreno DA, Tufi LMB, Ramos LP, Pereira LAB, et al. Cisplatin‑resistant germ cell tumor models: An exploration of the epithelial‑mesenchymal transition regulator SLUG. Mol Med Rep. 2024;30(6). 10.3892/mmr.2024.13352.

34. Afonso J, Barbosa-Matos C, Silvestre R, Pereira-Vieira J, Gonçalves SM, Mendes-Alves C, et al. Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect. Cancers (Basel). 2024;16(7). 10.3390/cancers16071418.

35. Alves da Quinta D, Rocha D, Retamales J, Giunta D, Artagaveytia N, Velazquez C, et al. Closing the gap: prognostic and predictive biomarker validation for personalized care in a Latin American hormone-dependent breast cancer cohort. Oncologist. 2024. 10.1093/oncolo/oyae191.

36. Arruda do Espirito Santo P, Meine GC, Baraldo S, Barbosa EC. Cold endoscopic mucosal resection versus cold snare polypectomy for colorectal lesions: a systematic review and meta-analysis of randomized controlled trials. Endoscopy. 2024. 10.1055/a-2275-5349.

37. Syrjänen K, Eskelinen M, Meklin J, Hendolin P, Eskelinen M, Suovaniemi O. Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB). Anticancer Res. 2024;44(4):1513-23. 10.21873/anticanres.16948.

38. McGillivray E, Ashouri K, Chatziioannou E, Gallegos JAO, Zarka J, Kechter J, et al. Combined PD-1 and CTLA-4 Blockade in an International Cohort of Patients with Acral Lentiginous Melanoma. Br J Dermatol. 2024. 10.1093/bjd/ljae401.

39. Ferreira MY, Antônia OMPM, Hemais M, Bocanegra-Becerra JE, Cheidde L, de Oliveira Almeida G, et al. Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis. J Neurooncol. 2024. 10.1007/s11060-024-04768-2.

40. Viani K, Furlong W, Filho VO, Santos Murra MD, Nabarrete JM, Ladas E, et al. Comprehensive health status and health-related quality of life of children at diagnosis of high-risk neuroblastoma: a multicentric pilot study. Hematol Transfus Cell Ther. 2024. 10.1016/j.htct.2024.05.014.

41. Santarosa Vieira AG, da Silva LS, Albino da Silva EC, Laus AC, Faria TMV, van Helvoort Lengert A, et al. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures. Mol Oncol. 2024;18(6):1593-607. 10.1002/1878-0261.13617.

42. Simione AJ, Silva CCd, Sabaini PMdS, Macedo AV, Neves HRAd, Geraldo BLdSS, et al. Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides – 2024. Journal of Bone Marrow Transplantation And Cellular Therapy. 2024;5(1):228. 10.46765/2675-374X.2024v5n1p228.

43. Tavares CAM, Azevedo LCP, Rea-Neto Á, Campos NS, Amendola CP, Kozesinski-Nakatani AC, et al. Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial. Jama. 2024. 10.1001/jama.2024.10510.

44. Saad F, Vjaters E, Shore N, Olmos D, Xing N, Pereira de Santana Gomes AJ, et al. Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial. J Clin Oncol. 2024:Jco2401798. 10.1200/jco-24-01798.

45. Bednar EM, Paiz KA, Lu KH, Soares Dias De Souza AP, Oliveira G, Andrade C, et al. Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico. Int J Gynecol Cancer. 2024. 10.1136/ijgc-2023-005190.

46. Birolli WG, Lanças FM, dos Santos Neto ÁJ, Silveira HC. Determination of pesticide residues in urine by chromatography-mass spectrometry: methods and applications. Frontiers in Public Health. 2024;12:1336014. 10.3389/fpubh.2024.1336014.

47. Lengert AVH, Tassinari TA, Lourenço ATO, Peronni KC, Castro P, Pereira JEM, et al. Development and evaluation of high-resolution melting assays for direct and simultaneous pathogen identification in bloodstream infections in pediatric oncology patients. Diagn Microbiol Infect Dis. 2024;110(3):116426. 10.1016/j.diagmicrobio.2024.116426.

48. Birolli WG, Lanças FM, Silveira HCS, Santos-Neto Á J. Development of a unified method for the determination of legacy and metabolites of current pesticides in serum for exposure assessment. Anal Bioanal Chem. 2024. 10.1007/s00216-024-05488-2.

49. Chubaci EF, Costa C, Santos Neto MFD, Dos Santos ER, Engel A, Costa A, et al. Development of Leadership Skills in Medical Education: Protocol for a Scoping Review. JMIR Res Protoc. 2024;13:e62810. 10.2196/62810.

50. Eskelinen M, Meklin J, Guimaraes DP, Selander T, Syrjänen K, Eskelinen M. The Diagnostic Accuracy (DA) of ColonView Fecal Immunochemical Test (FIT) in Detecting Colorectal Adenoma (CRA) Can Be Improved by the Diagnostic Models (DM) that Include Triage and Risk Features of CRA. Anticancer Res. 2024;44(1):173-84. 10.21873/anticanres.16800.

51. Scuglia M, Frazão LP, Miranda A, Martins A, Barbosa-Sequeira J, Coimbra D, et al. Diaphragmatic hernia repair porcine model to compare the performance of biodegradable membranes against Gore-Tex(®). Pediatr Surg Int. 2024;40(1):7. 10.1007/s00383-023-05584-x.

52. Faldoni FLC, Bizinelli D, Souza CP, Santana IVV, Marques MMC, Rainho CA, et al. DNA methylation profile of inflammatory breast cancer and its impact on prognosis and outcome. Clin Epigenetics. 2024;16(1):89. 10.1186/s13148-024-01695-x.

53. da Costa Vieira RA, Facina G, Tiezzi DG, Urban CA, de Freitas Junior R. Editorial: Oncoplastic surgery for breast cancer. Front Oncol. 2024;13:1348964. 10.3389/fonc.2023.1348964.

54. de Barros ESPGM, Macedo AVS, Bronhara B, Damiani LP, Mazza Barbosa L, Lopes NR, et al. Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial. Circulation. 2024;150(1):82-5. 10.1161/circulationaha.123.066709.

55. Mandalà M, Ferrari A, Brecht IB, Suijkerbuijk KP, Maschke L, Giannarelli D, et al. Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study). Eur J Cancer. 2024;211:114305. 10.1016/j.ejca.2024.114305.

56. Florencio de Mesquita C, Antunes V, Milioli NJ, Fernandes MV, Correa TL, Martins OC, et al. Endoscopic Ultrasound-Guided Coiling plus Glue Injection Compared with Endoscopic Glue Injection Alone in Endoscopic Treatment for Gastric Varices: A Systematic Review and Meta-Analysis. Gastrointest Endosc. 2024. 10.1016/j.gie.2024.10.005.

57. Arruda do Espirito Santo P, Meine GC, Nau AL, Barbosa EC, Baraldo S, Lenz L, et al. Endoscopic ultrasound-guided versus percutaneous liver biopsy: a systematic review and meta-analysis of randomized controlled trials. Endoscopy. 2024. 10.1055/a-2368-4608.

58. Datorre JG, Dos Reis MB, de Carvalho AC, Porto J, Rodrigues GH, Lima AB, et al. Enhancing Colorectal Cancer Screening with Droplet Digital PCR (ddPCR) Analysis of Fusobacterium nucleatum in Fecal Immunochemical Test (FIT) Samples. Cancer Prev Res (Phila). 2024. 10.1158/1940-6207.Capr-23-0331.

59. de Araújo TBS, Nogueira RLR, Siquara da Rocha LO, Bastos IN, Dias RB, Souza BSF, et al. Enhancing scaffold-free spheroid models: 3D cell bioprinting method for metastatic HSC3-Oral squamous carcinoma cell line. SLAS Discov. 2024;29(4):100158. 10.1016/j.slasd.2024.100158.

60. Oliveira L, Castro S, Freitas C, Silva R, Vieira F, Tostes R, et al. Epidemiology of breast cancer in a tertiary oncology hospital in the countryside of Minas Gerais. Mastology. 2024;34. 10.29289/2594539420230040.

61. Rohr P, Karen S, Francisco LFV, Oliveira MA, Dos Santos Neto MF, Silveira HCS. Epigenetic processes involved in response to pesticide exposure in human populations: a systematic review and meta-analysis. Environ Epigenet. 2024;10(1):dvae005. 10.1093/eep/dvae005.

62. Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, et al. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line. Hum Cell. 2024. 10.1007/s13577-024-01054-1.

63. Guimarães Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F. Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17. Cancer Causes Control. 2024;35(3):523-9. 10.1007/s10552-023-01812-w.

64. Barbosa EC, Santo P, Baraldo S, Nau AL, Meine GC. EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: A systematic review and meta-analysis of randomized controlled trials. Gastrointest Endosc. 2024. 10.1016/j.gie.2024.04.019.

65. Wood A, Pereira A, Araújo E, Ferigatto J, Buexm L, Barroso E, et al. Evaluation of the Impact of Oral Health on the Daily Activities of Users of the National Health System. Int J Environ Res Public Health. 2024;21(1). 10.3390/ijerph21010092.

66. Reid F, Adams T, Adel RS, Andrade CE, Bajwa A, Bambury IG, et al. The every woman study™ low- and middle-income countries edition protocol: A multi-country observational study to assess opportunities and challenges to improving survival and quality of life for women with ovarian cancer. PLoS One. 2024;19(5):e0298154. 10.1371/journal.pone.0298154.

67. Causin RL, Polezi MR, Freitas AJAd, Calfa S, Altei WF, Dias JO, et al. EV-miRNAs from breast cancer patients of plasma as potential prognostic biomarkers of disease recurrence. Heliyon. 2024;10(14). 10.1016/j.heliyon.2024.e33933.

68. Vieira IA, Viola GD, Pezzi EH, Kowalski TW, Fernandes BV, Andreis TF, et al. Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas. Genet Mol Biol. 2024;46(3 Suppl 1):e20230133. 10.1590/1678-4685-gmb-2023-0133.

69. Vieira R, Ibrahim MS, de Souza Araujo LG, Souza Junior JAE, de Freitas CSM, de Oliveira LCN. External breast prostheses after mastectomy: production and selection of a low-cost functional model to be performed in developing countries. Front Oncol. 2024;14:1440109. 10.3389/fonc.2024.1440109.

70. Buccheri V, Moreira FR, Biasoli I, Castro N, Villarim CC, Traina F, et al. External validation and calibration of the HoLISTIC Consortium’s advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registry. Br J Haematol. 2024. 10.1111/bjh.19824.

71. Vieira R, Paulinelli RR, de Oliveira-Junior I. Extreme oncoplasty: past, present and future. Front Oncol. 2024;13:1215284. 10.3389/fonc.2023.1215284.

72. Bednar EM, Nitecki Wilke R, Jorgensen K, Walsh MT, Jr., Nutt S, Lu KH, et al. Feasibility of an environmental scan-based approach to collecting information about factors impacting cancer genetics services in Latin American countries. J Community Genet. 2024. 10.1007/s12687-024-00744-5.

73. Janjigian YY, Ajani JA, Moehler M, Shen L, Garrido M, Gallardo C, et al. First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. J Clin Oncol. 2024:Jco2301601. 10.1200/jco.23.01601.

74. Palavani LB, Silva GM, Borges P, Ferreira MY, Sousa MP, Leite M, et al. Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis. J Neurooncol. 2024. 10.1007/s11060-024-04621-6.

75. Nunes F, de Gusmão BM, Wiginesk FB, Manenti E, Soares J, Freitas MG, et al. From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy. Hematol Transfus Cell Ther. 2024. 10.1016/j.htct.2024.06.008.

76. Abreu RBV, Pereira AS, Rosa MN, Ashton-Prolla P, Silva VAO, Melendez ME, et al. Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li-Fraumeni syndrome. Sci Rep. 2024;14(1):17187. 10.1038/s41598-024-67810-3.

77. Vieira IA, Pezzi EH, Bandeira IC, Reis LB, de Araújo Rocha YM, Fernandes BV, et al. Functional pri-miR-34b/c rs4938723 and KRAS 3’UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome? Gene. 2024;898:148069. 10.1016/j.gene.2023.148069.

78. Bondok M, Nguyen AX, Tanya SM, Youn GM, Lando L, Wu AY. Gender and personalized profile information influence online ratings of Canadian academic ophthalmologists. Can J Ophthalmol. 2024. 10.1016/j.jcjo.2024.09.002.

79. Goes JVC, Viana MA, Sampaio LR, Cavalcante CBA, Melo MML, de Oliveira RTG, et al. Gene expression patterns of Sirtuin family members (SIRT1 TO SIRT7): Insights into pathogenesis and prognostic of Myelodysplastic neoplasm. Gene. 2024;915:148428. 10.1016/j.gene.2024.148428.

80. De Marchi P, Leal LF, da Silva LS, Cavagna RO, da Silva FAF, da Silva VD, et al. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC. Transl Oncol. 2024;39:101818. 10.1016/j.tranon.2023.101818.

81. Senkin S, Moody S, Díaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 2024;629(8013):910-8. 10.1038/s41586-024-07368-2.

82. Pereira-Vieira J, Weber DD, Silva S, Barbosa-Matos C, Granja S, Reis RM, et al. Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia. J Pharmaceutics. 2024;16(4):442. 10.3390/pharmaceutics16040442.

83. Paiva BSR, Mingardi M, de Almeida LF, de Camargos MG, Valentino TCO, Julião M, et al. Go Wish card game-exploring end-of-life wishes of patients in oncology palliative care: a qualitative study. Ann Palliat Med. 2024;13(1):31-41. 10.21037/apm-23-381.

84. Custódio IDD, Nunes FSM, Lima MTM, Carvalho KP, Machado AM, Lajolo PP, et al. Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapy. Clinics (Sao Paulo). 2024;79:100324. 10.1016/j.clinsp.2024.100324.

85. de Bastos DR, Longatto-Filho A, Conceição MPF, Termini L. High Levels of Superoxide Dismutase 2 Are Associated With Worse Prognosis in Patients With Breast Cancer. Eur J Breast Health. 2024;20(3):185-93. 10.4274/ejbh.galenos.2024.2024-3-6.

86. Ferreira J, Roque S, Longatto-Filho A, Afonso J, Carneiro A, Vila I, et al. Higher levels of cytokines in patients with critical limb threatening ischemia. Ann Vasc Surg. 2024. 10.1016/j.avsg.2024.02.033.

87. Campacci N, Grasel RS, Galvão HCR, Garcia LF, Ribeiro PC, Pereira K, et al. The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing? Front Psychol. 2024;15:1306388. 10.3389/fpsyg.2024.1306388.

88. González-Cao M, Cai X, Bracht JWP, Han X, Yang Y, Pedraz-Valdunciel C, et al. HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer. Lung Cancer (Auckl). 2024;15:55-67. 10.2147/lctt.S455034.

89. Sorroche BP, Miranda KC, Beltrami CM, Arantes L, Kowalski LP, Marchi FA, et al. HOXA1 3’UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma. Cancers (Basel). 2024;16(5). 10.3390/cancers16050874.

90. Bernardi FDC, Algranti E, Dolhnikoff M, Pinto CAL, Oliveira IM, Coletta E, et al. Identifying malignant mesothelioma by a pathological survey using the São Paulo state hospital cancer registry, Brazil. J Bras Pneumol. 2024;50(2):e20230343. 10.36416/1806-3756/e20230343.

91. Zucca LER, Laus AC, Sorroche BP, Paro E, Sussuchi L, Marques RF, et al. Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer. Transl Oncol. 2024;46:102003. 10.1016/j.tranon.2024.102003.

92. Teixeira RJ, de Souza VG, Sorroche BP, Paes VG, Zambuzi-Roberto FA, Pereira CAD, et al. Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy. Melanoma Res. 2024. 10.1097/cmr.0000000000000958.

93. Singer S, Sykiotis G, Al-Ibraheem A, Pinto M, Iakovou I, Østhus AA, et al. The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patients. Endocrine. 2024;84(2):635-45. 10.1007/s12020-023-03628-9.

94. Teixeira MR, Oliveira GDS, Andrade C, Schmidt RL, Teodoro VA, Pedrão PG, et al. Impact of Preoperative Counseling and Education on Decreasing Anxiety in Patients With Gynecologic Tumors: A Randomized Clinical Trial. J Surg Oncol. 2024. 10.1002/jso.27942.

95. Peixoto M, Viana-Pereira M, Amorim MJ, Marques AD, Freitas D, Cunha J, et al. Impact of Suppressor of Mothers Against Decapentaplegic (SMAD) 7 Gene Single Nucleotide Polymorphisms on Colorectal Cancer Risk and Prognosis. Cureus. 2024;16(9). 10.7759/cureus.7008.

96. Peixoto M, Viana-Pereira M, Amorim MJ, Marques AD, Freitas D, Cunha J, et al. Impact of Suppressor of Mothers Against Decapentaplegic (SMAD) 7 Gene Single Nucleotide Polymorphisms on Colorectal Cancer Risk and Prognosis. Cureus. 2024;16(9):e70081. 10.7759/cureus.70081.

97. Vianna FSL, Neves LL, Testa R, Nassar AP, Jr., Peres JHF, da Silva RÁ J, et al. Impact of the COVID-19 Pandemic on the Outcomes of Patients Undergoing Oncological Surgeries: CORONAL Study. Ann Surg Oncol. 2024. 10.1245/s10434-024-15152-9.

98. Retamales J, Daneri-Navarro A, Artagaveytia N, Alves da Quinta D, Abdelhay E, Podhajcer OL, et al. Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial. JCO Glob Oncol. 2024;10:e2300216. 10.1200/go.23.00216.

99. Carvalho L, de Lima FP, Cerqueira M, Silva A, Pontes O, Oliveira-Pinto S, et al. In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC Med Chem. 2024;15(4):1362-80. 10.1039/d3md00682d.

100. Veiga VC, Peres SV, Ostolin T, Moraes FR, Belucci TR, Clara CA, et al. Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis. PLoS One. 2024;19(6):e0304682. 10.1371/journal.pone.0304682.

101. Chavan R, Baraldo S, Rajput S. Inclusion of Patients With Duodenal Obstruction in Endoscopic Retrograde Cholangiopancreatography Group: Not a Right Intention. Gastroenterology. 2024;166(1):215. 10.1053/j.gastro.2023.05.011.

102. Vieira TDS, Freitas FV, Silva Neto LCB, Borçoi AR, Barbosa WM, Olinda AS, et al. An industrialized diet as a determinant of methylation in the 1F region of the NR3C1 gene promoter. Frontiers in Nutrition. 2024;11:1168715. 10.3389/fnut.2024.1168715.

103. Ferreira J, Afonso J, Longatto-Filho A, Roque S, Carneiro A, Vila I, et al. Inflammation Is a Histological Characteristic of Skeletal Muscle in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2024;99:10-8. 10.1016/j.avsg.2023.09.094.

104. Calanca N, Faldoni FLC, Souza CP, Souza JS, de Souza Alves BE, Soares MBP, et al. Inflammatory breast cancer microenvironment repertoire based on DNA methylation data deconvolution reveals actionable targets to enhance the treatment efficacy. J Transl Med. 2024;22(1):735. 10.1186/s12967-024-05553-5.

105. Ferreira J, Longatto-Filho A, Afonso J, Roque S, Carneiro AL, Vila I, et al. Inflammatory Cells in Adipose Tissue and Skeletal Muscle of Patients with Peripheral Arterial Disease or Chronic Venous Disease: A Prospective, Observational, and Histological Study. J Cardiovasc Dev Dis. 2024;11(4). 10.3390/jcdd11040121.

106. Palavani LB, Camerotte R, Vieira Nogueira B, Ferreira MY, Oliveira LB, Pari Mitre L, et al. Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: A systematic review and single-arm meta-analysis. J Clin Neurosci. 2024;128:110774. 10.1016/j.jocn.2024.110774.

107. Dellalibera-Joviliano R, Garcia ME, Marins M, Fachin A, Couto LB, Mesquita E, et al. Interleukin-12 treatment reduces tumor growth and modulates the expression of CASKA and MIR-203 in athymic mice bearing tumors induced by the HGC-27 gastric cancer cell line. Pathol Res Pract. 2024;263:155625. 10.1016/j.prp.2024.155625.

108. Riedmeier M, Antonini SRR, Brandalise S, Costa T, Daiggi CM, de Figueiredo BC, et al. International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects. Eur J Endocrinol. 2024;190(4):G15-g24. 10.1093/ejendo/lvae038.

109. Patrón Uriburu JC, Araujo S, Mario A, Billy J, Méndez R, Rossi G, et al. Intracorporeal anastomosis could be associated with a higher lymph node yield in right colon cancer surgery: Results of the ICA-LATAM study, a retrospective, multicentre, comparative analysis in Latin America. Colorectal Dis. 2024;26(5):940-8. 10.1111/codi.16962.

110. Cappellano AM, Dassi N, Mançano BM, Epelman S, Almeida DB, Cavalheiro S, et al. Intracranial non-germinomatous germ cell tumors in children and adolescents: how can the experience from an uppermiddle-income country contribute to the worldwide effort to improve outcomes? Front Oncol. 2024;14:1308128. 10.3389/fonc.2024.1308128.

111. Lima de Souza R, Teixeira Pinto T, Moraes Losada D, Lando L. Intraoperative assessment of periorbital nodular fasciitis presenting as unilateral, acquired S-shaped ptosis. Orbit. 2024:1. 10.1080/01676830.2024.2412124.

112. Reis RJ, Medeiros LR, Reis R, Zanon JR, Avila R, Souza MM. Is infracolic omentectomy necessary for early-stage (FIGO I–II) borderline ovarian tumors? A protocol for systematic review and meta-analysis. International Journal of Surgery Protocols. 9900. 10.1097/SP9.0000000000000028.

113. de Arruda JAA, Oliveira SR, Heimlich FV, de Amorim-Santos BM, Schneider AH, de Sena A, et al. Kinetics of neutrophil extracellular traps and cytokines in oral mucositis and Candida infection. Oral Dis. 2024. 10.1111/odi.14857.

114. Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al. Latin American Consensus on the Treatment of Head and Neck Cancer. JCO Glob Oncol. 2024;10:e2300343. 10.1200/go.23.00343.

115. Pontes JGM, Jadranin M, Assalin MR, Quintero Escobar M, Stanisic D, Costa T, et al. Lipidomics by Nuclear Magnetic Resonance Spectroscopy and Liquid Chromatography-High-Resolution Mass Spectrometry in Osteosarcoma: A Pilot Study. Metabolites. 2024;14(8). 10.3390/metabo14080416.

116. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, et al. Long-term health-related quality of life in head and neck cancer survivors: A large multinational study. Int J Cancer. 2024. 10.1002/ijc.34861.

117. Buzatto IPC, Recife SA, Miguel L, Bonini RM, Onari N, Faim A, et al. Machine learning can reliably predict malignancy of breast lesions based on clinical and ultrasonographic features. Breast Cancer Res Treat. 2024. 10.1007/s10549-024-07429-0.

118. Paiva CE, Zonta MPM, Granero RC, Guimarães VS, Pimenta LM, Teixeira GR, et al. The Magee 3 Equation Predicts Favorable Pathologic Response to Neoadjuvant Endocrine Therapy in Breast Cancer Patients. Cancers (Basel). 2024;16(2). 10.3390/cancers16020339.

119. Faria EF, Maciel CVM, Melo PA, Tobias-Machado M, Dias RM, Dos Reis RB, et al. Mesentery-Sparing Technique: a New Intracorporeal Approach for Urinary Diversion in Robot-Assisted Radical Cystectomy. Int Braz J Urol. 2024;50(4):489-99. 10.1590/s1677-5538.Ibju.2024.0153.

120. Welsh JA, Goberdhan DCI, O’Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404. 10.1002/jev2.12404.

121. Cavagna RO, Escremim de Paula F, Berardinelli GN, Bonatelli M, Santana I, Albino da Silva EC, et al. Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies. Oncologist. 2024. 10.1093/oncolo/oyae129.

122. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, et al. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 2024. 10.1038/s41588-024-01725-7.

123. Brenes D, Salcedo MP, Coole JB, Maker Y, Kortum A, Schwarz RA, et al. Multiscale Optical Imaging Fusion for Cervical Precancer Diagnosis: Integrating Widefield Colposcopy and High-Resolution Endomicroscopy. IEEE Trans Biomed Eng. 2024;Pp. 10.1109/tbme.2024.3379898.

124. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 2024:100500. 10.1016/j.xgen.2024.100500.

125. Ritter J, de Bragança J, Auste C, Mendez A, Cohen PD, Fajardo AF, et al. Novel Framework of Financial Hardship in Childhood Cancer: Incorporating Stakeholder Perspectives. JCO Glob Oncol. 2024;10:e2400093. 10.1200/go.24.00093.

126. Stelet VN, Romero M, Cita RF, Binato R, Abdelhay E. A novel HLA-C*02:10 variant, HLA-C*02:10:09, identified in a healthy individual from Brazil. Hla. 2024;103(2):e15410. 10.1111/tan.15410.

127. Teixeira-Pinto T, Lima de Souza R, Grossi Marconi D, Lando L. Ophthalmic rehabilitation in oncology care. Can J Ophthalmol. 2024. 10.1016/j.jcjo.2024.07.004.

128. Vazquez FL, Coracin FL, Arantes K, Ferigatto JL, Nascimento-Júnior AC, Barroso EM, et al. An oral cancer screening program in Brazil: Analysis of seven years of outcome after its implementation in the suburban cities of São Paulo. Oral Oncol. 2024;154:106826. 10.1016/j.oraloncology.2024.106826.

129. Santos FA, Reis RM, Barroti LC, Pereira AAL, Matsushita MM, de Carvalho AC, et al. Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer. J Gastrointest Cancer. 2024;55(1):344-54. 10.1007/s12029-023-00964-x.

130. Junior JNA, Preto DD, Lazarini M, de Lima MA, Bonatelli M, Berardinelli GN, et al. PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site. Int J Clin Oncol. 2024. 10.1007/s10147-024-02494-3.

131. Ferreira J, Longatto-Filho A, Dionísio A, Correia-Neves M, Cunha P, Mansilha A. Peri-Carotid Adipose Tissue and Atherosclerosis at Carotid Bifurcation. J Cardiovasc Dev Dis. 2024;11(2). 10.3390/jcdd11020058.

132. Hui D, Cheng SY, Paiva CE. Pharmacologic Management of End-of-Life Delirium: Translating Evidence into Practice. Cancers (Basel). 2024;16(11). 10.3390/cancers16112045.

133. Fontes MS, de Almeida DVP, Cárcano F, Lages P, Dienstmann R. Precision medicine for urothelial carcinoma: An international perspective. Urol Oncol. 2024. 10.1016/j.urolonc.2023.11.008.

134. de Barros ESPGM, Furtado RHM, de Alcântara Chaud MS, Macedo AVS, Bronhara B, Damiani LP, et al. Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial. J Thromb Thrombolysis. 2024. 10.1007/s11239-024-02995-y.

135. McNeil MJ, Garcia Quintero X, Gonzalez M, Zheng Y, Ugaz Olivares C, Morales R, et al. Preventing and Treating Pain and Anxiety during Needle-Based Procedures in Children with Cancer in Low- and Middle-Income Countries. Cancers (Basel). 2024;16(5). 10.3390/cancers16051025.

136. Martins TS, Henrique FJFS, Birolli WG, Bott-Neto JL, Silveira HCS, Esteves PM, et al. Printed strips coated with a reticular organic framework for Non-Enzymatic detection of pesticides in the urine of rural workers. Chemical Engineering Journal. 2024;496:154027. https://doi.org/10.1016/j.cej.2024.154027.

137. Maia IS, Medrado FA, Jr., Tramujas L, Tomazini BM, Oliveira JS, Sady ERR, et al. Prospective, randomized, controlled trial assessing the effects of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome due to community-acquired pneumonia (STAMINA trial): protocol and statistical analysis plan. Crit Care Sci. 2024;36:e20240210en. 10.62675/2965-2774.20240210-en.

138. Lordelo MV, Oliveira CZ, Aguirre Buexm L, Vieira Reis RM, Longatto-Filho A, Possati-Resende JC, et al. Randomized experimental population-based study to evaluate the acceptance and completion of and preferences for cervical cancer screening. PLoS One. 2024;19(8):e0306130. 10.1371/journal.pone.0306130.

139. Barbosa EC, Espírito Santo PA, Baraldo S, Meine GC. Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. Br J Anaesth. 2024. 10.1016/j.bja.2024.02.005.

140. Diniz JBC, Alfonso Rodriguez Elvir F, Silva Santana L, Batista S, Glioche Gasparri L, Mota Telles JP, et al. Replacement of traditional vagus nerve stimulation with cardiac-based device and seizure reduction: A systematic review and meta-analysis. Seizure. 2024;118:65-70. 10.1016/j.seizure.2024.04.001.

141. Lima JA, Sorroche BP, Tostes K, Dias TC, de Carvalho Rodrigues N, Tansini A, et al. Repurposing discarded leukodepletion filters as a source of mononuclear cells for advanced in vitro research. J Immunol Methods. 2024;530:113694. 10.1016/j.jim.2024.113694.

142. Arias AV, Lintner-Rivera M, Shafi NI, Abbas Q, Abdelhafeez AH, Ali M, et al. A research definition and framework for acute paediatric critical illness across resource-variable settings: a modified Delphi consensus. Lancet Glob Health. 2024;12(2):e331-e40. 10.1016/s2214-109x(23)00537-5.

143. Paiva CE, Silva ATF, Oliveira IDS, Guimarães VS, Lacerda DC, Teixeira GR, et al. A Research Protocol for a Phase II Single-Arm Clinical Trial Assessing the Feasibility and Efficacy of Neoadjuvant Anastrozole in Patients With Luminal Breast Cancer and Low Proliferative Index: The ANNE Trial. Cancer Control. 2024;31:10732748241272463. 10.1177/10732748241272463.

144. Ferreira J, Roque S, Lima Carneiro A, Longatto-Filho A, Vila IN, Cunha C, et al. Reversion of the Inflammatory Markers in Patients With Chronic Limb-Threatening Ischemia. J Am Heart Assoc. 2024;13(8):e031922. 10.1161/jaha.123.031922.

145. Groisman Sieben R, Paternina-de la Ossa R, Waack A, Casale Aragon D, Bellissimo-Rodrigues F, Israel do Prado S, et al. Risk factors and mortality of candidemia in a children’s public hospital in Sao Paulo, Brazil. Rev Argent Microbiol. 2024. 10.1016/j.ram.2023.09.002.

146. Kremer V, Oliveira Junior WE. The role of Pediatric Surgery in childhood cancer. Rev Assoc Med Bras (1992). 2024;70(suppl 1):e2024S110. 10.1590/1806-9282.2024s110.

147. Ubinha ACF, Pedrão PG, Tadini AC, Schmidt RL, Santos MHD, Andrade C, et al. The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature. Cancers (Basel). 2024;16(4). 10.3390/cancers16040817.

148. Ferreira MY, Porto Junior S, Batista S, Semione G, Borges P, Porto de Oliveira JV, et al. Same-day discharge in craniotomy: A systematic review and meta-analysis. J Clin Neurosci. 2024;126:202-13. 10.1016/j.jocn.2024.06.013.

149. Valença FRT, Dos Santos Neto MF, Sacardo Y, Oliani D, Santos ERD, Brienze VMS, et al. A Scoping Review Protocol to Map Knowledge and Attitudes about Patient Safety among Students in Healthcare Undergraduate Courses. Nurs Rep. 2024;14(3):2014-9. 10.3390/nursrep14030150.

150. Vázquez-Iglesias L, Stanfoca Casagrande GM, García-Lojo D, Ferro Leal L, Ngo TA, Pérez-Juste J, et al. SERS sensing for cancer biomarker: Approaches and directions. Bioact Mater. 2024;34:248-68. 10.1016/j.bioactmat.2023.12.018.

151. Gomes FC, Ferreira MY, Larcipretti ALL, Freitas BCB, Andreão FF, Turpin J, et al. Sodium fluorescein and 5-aminolevulinic acid fluorescence- guided biopsy in brain lesions: a systematic review and meta-analysis. Journal of Neuro-Oncology. 2024. 10.1007/s11060-024-04779-z.

152. Barateiro L, de Oliveira Cavagna R, Dos Reis MB, de Paula FE, Teixeira GR, Moreno DA, et al. Somatic mutational profiling and clinical impact of driver genes in Latin-Iberian medulloblastomas: Towards precision medicine. Neuropathology. 2024. 10.1111/neup.12979.

153. Rabelo BS, de Alvarenga KAF, Fernando Lopes L, Guimarães Ribeiro A, de Sá Rodrigues KE. Strategies to improve diagnosis and access to treatment of retinoblastoma in low- and middle-income countries: A systematic review. Pediatr Blood Cancer. 2024;71(7):e30987. 10.1002/pbc.30987.

154. Ferreira MY, Thomaz de Assis EB, Batista S, Palavani LB, Verly G, Corrêa EM, et al. Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis. World Neurosurg. 2024. 10.1016/j.wneu.2024.01.006.

155. Oliveira AGS, Rocha MA, de Azevedo LS, Coelho ATM, Chagas RCR, Santos HB, et al. Tapirira guianensis is Selectively Cytotoxic, Induces Apoptosis to the Glioblastoma and Decreases Tumor Growth and Angiogenesis in vivo. Planta Med. 2024;90(1):13-24. 10.1055/a-2181-2569.

156. Souza RL, Teixeira-Pinto T, Reis MT, Lando L. Tarsal Sebaceoma Presenting as a Papillomatous Lesion. Ophthalmic Plast Reconstr Surg. 2024. 10.1097/iop.0000000000002721.

157. Chavan R, Baraldo S, Patel N, Gandhi C, Rajput S. Technical tips for EUS-guided embolization of varices and pseudoaneurysms. VideoGIE. 2024;9(4):211-9. 10.1016/j.vgie.2023.12.006.

158. Sampor C, Alonso R, Durañona M, Gorostegui M, Antillón-Klussmann F, Lopes LF, et al. The TeLeo Program: Tele-education in pediatric oncology as a tool to support training programs in Latin America. Pediatr Blood Cancer. 2024:e31335. 10.1002/pbc.31335.

159. Ebel L, Autrán AM, Rodríguez-Faba O, Alcántara C. Testicular cancer in Ibero-America: Proper prevention and diagnostic strategies. Actas Urol Esp (Engl Ed). 2024. 10.1016/j.acuroe.2024.06.002.

160. Carvalho BF, Gomez GVB, Carron J, Macedo LT, Gonçalves GM, Vazquez VL, et al. TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma. Int J Mol Sci. 2024;25(5). 10.3390/ijms25052868.

161. Dutta D, Guo X, Winter TD, Jahagirdar O, Ha E, Susztak K, et al. Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma. Am J Hum Genet. 2024;111(9):1864-76. 10.1016/j.ajhg.2024.07.012.

162. Bennemann ACK, Paiva CE, Julião M, Chochinov HM, Marques C, Costa RFA, et al. Translation and cross-cultural adaptation of the Posthumous Dignity Therapy Schedule of Questions to Brazilian Portuguese. Palliat Support Care. 2024:1-10. 10.1017/s1478951524001408.

163. Palavani LB, Ferreira MY, Borges P, Bandeira L, da Silva Semione G, Almeida MV, et al. Ultrasound-Guided Resection of High-Grade Gliomas: A Single-Arm Meta-Analysis. World Neurosurg. 2024;186:17-26. 10.1016/j.wneu.2024.03.033.

164. Garcia ALH, de Souza MR, Picinini J, Soares S, Rohr P, Linden R, et al. Unraveling gene expression and genetic instability in dental fluorosis: Investigating the impact of chronic fluoride exposure. Sci Total Environ. 2024;906:167393. 10.1016/j.scitotenv.2023.167393.

165. Wang W, Kumm ZT, Ho C, Zanesco-Fontes I, Texiera G, Reis RM, et al. Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation. Neurooncol Adv. 2024;6(1):vdad140. 10.1093/noajnl/vdad140.

166. Cardoso-Carneiro D, Pinheiro J, Fontão P, Nogueira R, Gabriela-Freitas M, Raquel-Cunha A, et al. Unveiling the RKIP and EGFR Inverse Relationship in Solid Tumors: A Case Study in Cervical Cancer. Cancers (Basel). 2024;16(12):2182. 10.3390/cancers16122182.

167. Arantes L, Silva-Oliveira RJ, de Carvalho AC, Melendez ME, Sorroche BP, de Jesus Teixeira R, et al. Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment. Head Neck. 2024;46(3):461-72. 10.1002/hed.27602.

168. Katz LMC, Vasconcelos ALRd, Oliveira SRdA, Resende JCP, Carvalho AL. Validation of the colposcopic report for screening intraepithelial lesions and cervical cancer. International Journal Of Community Medicine And Public Health. 2024;11(7):2895-900. 10.18203/2394-6040.ijcmph20241854.

169. Milioli NJ, Fernandes MV, Correa TL, Antunes V, Martins OC, Florêncio de Mesquita C, et al. Vedolizumab versus ustekinumab in Crohn’s disease with prior anti-tumor necrosis factor failure: an updated meta-analysis. Eur J Gastroenterol Hepatol. 2024;36(9):1068-74. 10.1097/meg.0000000000002817.

170. Straus Takahashi M, Gustavo Ieiri Yamanari M, Henrique de Marqui Moraes P, Iglesias Lopes R, Chammas MC. Vesicoureteral reflux by contrast ultrasound, comparison with voiding and retrograde urethrocystography: A prospective accuracy study. J Pediatr Urol. 2024;20(1):133.e1-.e9. 10.1016/j.jpurol.2023.10.014.

171. Trevizan FB, Paiva CE, de Almeida LF, de Oliveira MA, Bruera E, Paiva BSR. When and how to discuss about palliative care and advance care planning with cancer patients: A mixed-methods study. Palliat Support Care. 2024;22(2):387-95. 10.1017/s1478951523001517.